Table 3B.
AUC/Sensitivity/Specificity | |||||
---|---|---|---|---|---|
miRNAs | Combination miRNAs | cTnI | hs-cTnT | cTnT | CK-MB |
0.74*; 0.81/76%/88%** | 0.81*#; 0.89/78%/92%*## | 0.77*; 0.68/48%/98%** | 0.73* | ||
0.65*; 0.76/51%/94%** | |||||
0.7*; 0.78/58%/96%** | |||||
0.86/80%/80.28% | 0.90 | 0.82 | |||
0.949, 0.947, 0.791*** | 0.989, 1.000, 0.995# | 1.000, 1.000, 1.000*** | |||
0.881, 0.883, 0.838*** | |||||
0.798, 0.801, 0.908*** | |||||
0.855 | 0.902 |
The samples were obtained from or after T0. T08, the samples were obtained at 2.2 ± 0.97 h after the onset of chest pain on admission; T09, the time of chest pain; T010, the samples were obtained at 12.4 ± 1.5 h after the onset of AMI symptoms; T011, the time of onset of AMI; , lowest time; , sustain increase;
the AUC of miRNAs or classical biomarkers in patients with AMI (including all time points);
the AUC of miRNAs or classical biomarkers in patients with chest pain for <3 h;
the AUC of combined miRNAs in patients with AMI (including all time points);
the AUC of combined miRNAs in patients with chest pain for <3 h;
the AUC of miRNAs or classical biomarkers at T0 and 4 and 24 h;
the AUC of combination of miRNAs at T0 and 4 and 24 h.